Article Details
Retrieved on: 2021-01-05 21:45:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Roche's fericimab is the focus of Yosemite and Rhine studies, which investigators say show it has the potential to offer lasting vision improvements for ...
Article found on: www.ophthalmologytimes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here